WHO ICTRP trial
Sublingual misoprostol and oxytocin versus oxytocin alone for preventing primary…
PACTR202506646284255 · Pan African Clinical Trials Registry (PACTR) · Not Recruiting
Key facts
| Trial ID | PACTR202506646284255 |
|---|---|
| Public title | Sublingual misoprostol and oxytocin versus oxytocin alone for preventing primary postpartum hemorrhage after vaginal delivery in Nnamdi Azikiwe University Teaching Hospital Nnewi, Nigeria: A double-blind randomised placebo controlled study |
| Scientific title | Sublingual misoprostol and oxytocin versus oxytocin alone for preventing primary postpartum hemorrhage after vaginal delivery in Nnamdi Azikiwe University Teaching Hospital Nnewi, Nigeria: A double-blind randomised placebo controlled study |
| Primary sponsor | Ogonna Ezenwafor |
| Registry | Pan African Clinical Trials Registry (PACTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Nigeria |
| Conditions | Pregnancy and Childbirth;Pregnancy and Childbirth |
| Interventions | Misoprostol and oxytocin ;Oxytocin 10 i.u |
| Registration date | Jun 19, 2025 |
| Target size | 198 |
| Registry page | pactr.samrc.ac.za |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: